Pharmacy Law Lowdown

This episode explores PBMs’ copay collection discrepancies and how improper documentation can be the downfall for pharmacy business.

This episode highlights the FDA’s announcement regarding GLP-1 supply stabilization and critical compliance strategies for 503A pharmacies.

Featuring pharmacist and entrepreneur Sam Maddula, PharmD, this episode explores some key legislative and regulatory insights regarding owning and operating a pharmacy business.

This episode highlights key DSCSA updates in 2026, T3 documentation going forward, and many more developments surrounding the law.

This episode highlights the landmark FTC settlement with Express Scripts and what independent pharmacies and plan sponsors can expect going forward.

This episode explores important insights on PBM reform and what pharmacies can look out for throughout 2026.

This episode explores ongoing developments in pharmacy law, specifically for independent pharmacies and their representatives who attended the 2025 NCPA Convention & Expo.

This episode introduces the hosts and explores key legal issues facing independent pharmacies, including PBM terminations and state board compliance.

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.